Catalysts for $MRK
34 tracked
Oct 29, 2026
earnings
Merck & Co., Inc. earnings
Merck & Co., Inc.
→
Aug 4, 2026
earnings
Merck & Co., Inc. earnings
Merck & Co., Inc.
→
Apr 30, 2026
earnings
Merck & Co., Inc. earnings
Merck & Co., Inc.
→
Apr 30, 2026
phase 2 completion
Merck & Co Inc — tulisokibart (Phase II Trial Completion)
tulisokibart
→
Apr 30, 2026
phase 2 completion
Merck & Co Inc — pembrolizumab (Phase II Trial Completion)
pembrolizumab
→
Apr 30, 2026
phase 1 initiation
Merck & Co Inc — MK-6050 (Phase I Trial Initiation)
MK-6050
→
Apr 28, 2026
pdufa
Merck & Co Inc — (doravirine + islatravir hydrate) (PDUFA)
(doravirine + islatravir hydrate)
→
Jan 27, 2026
approval
NOXAFIL POWDERMIX KIT (POSACONAZOLE) — FDA approval
POSACONAZOLE
→
Jan 21, 2026
approval
VERQUVO (VERICIGUAT) — FDA approval
Merck & Co., Inc.
→
Dec 9, 2025
approval
RECARBRIO (CILASTATIN SODIUM) — FDA approval
(cilastatin sodium + imipenem + relebactam)
→
Oct 29, 2025
approval
DELSTRIGO (DORAVIRINE) — FDA approval
(doravirine + lamivudine + tenofovir disoproxil fumarate)
→
Oct 29, 2025
approval
PIFELTRO (DORAVIRINE) — FDA approval
doravirine
→
Sep 19, 2025
grant
GLYCYX MOR, INC. — A Phase 2 Trial of Axelopran Plus Pembrolizumab for the First-Line Treatment ...
Merck & Co., Inc.
→
Aug 20, 2025
recall
Merck & Co. Inc recall (Cls II)
Merck & Co., Inc.
→
Jun 12, 2025
approval
DELSTRIGO (DORAVIRINE) — FDA approval
(doravirine + lamivudine + tenofovir disoproxil fumarate)
→
Nov 7, 2024
approval
DELSTRIGO (DORAVIRINE) — FDA approval
(doravirine + lamivudine + tenofovir disoproxil fumarate)
→
Nov 7, 2024
approval
PIFELTRO (DORAVIRINE) — FDA approval
doravirine
→
Oct 25, 2024
approval
NOXAFIL POWDERMIX KIT (POSACONAZOLE) — FDA approval
POSACONAZOLE
→
May 10, 2023
approval
VERQUVO (VERICIGUAT) — FDA approval
Merck & Co., Inc.
→
Nov 21, 2022
approval
VERQUVO (VERICIGUAT) — FDA approval
Merck & Co., Inc.
→
Jan 27, 2022
approval
DELSTRIGO (DORAVIRINE) — FDA approval
(doravirine + lamivudine + tenofovir disoproxil fumarate)
→
Jan 27, 2022
approval
PIFELTRO (DORAVIRINE) — FDA approval
doravirine
→
Jan 20, 2022
approval
NOXAFIL POWDERMIX KIT (POSACONAZOLE) — FDA approval
POSACONAZOLE
→
Jan 13, 2022
approval
NOXAFIL POWDERMIX KIT (POSACONAZOLE) — FDA approval
POSACONAZOLE
→
May 31, 2021
approval
NOXAFIL POWDERMIX KIT (POSACONAZOLE) — FDA approval
POSACONAZOLE
→
Jan 19, 2021
approval
VERQUVO (VERICIGUAT) — FDA approval
Merck & Co., Inc.
→
Jun 4, 2020
approval
RECARBRIO (CILASTATIN SODIUM) — FDA approval
(cilastatin sodium + imipenem + relebactam)
→
Oct 10, 2019
approval
DELSTRIGO (DORAVIRINE) — FDA approval
(doravirine + lamivudine + tenofovir disoproxil fumarate)
→
Oct 10, 2019
approval
PIFELTRO (DORAVIRINE) — FDA approval
doravirine
→
Sep 19, 2019
approval
DELSTRIGO (DORAVIRINE) — FDA approval
(doravirine + lamivudine + tenofovir disoproxil fumarate)
→